{"database": "openregs", "table": "documents", "rows": [["FDA-2008-N-0039-0031", "FDA", "FDA-2008-N-0039", "FOI Summary for ZILMAX plus RUMENSIN plus TYLAN plus MGA, NADA 141-280 (Zilpaterol Hydrochloride and Monensin USP and Tylosin Phosphate and Melengestrol Acetate)", "Supporting & Related Material", "Freedom of Information Summary", "2008-04-08T04:00:00Z", 2008, 4, null, null, "2013-07-10T17:49:51Z", null, 0, 0, "090000648046e774"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2008-N-0039-0031"], "units": {}, "query_ms": 178.8387238048017, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}